These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22676197)

  • 1. Return of research results from pharmacogenomic versus disease susceptibility studies: what's drugs got to do with it?
    Dressler LG
    Pharmacogenomics; 2012 Jun; 13(8):935-49. PubMed ID: 22676197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disclosure of individual pharmacogenomic results in research projects: when and what kind of information to return to research participants.
    Korol S; Hurlimann T; Godard B; de Denus S
    Pharmacogenomics; 2013 Apr; 14(6):675-88. PubMed ID: 23570470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of genomic results to research participants: the floor, the ceiling, and the choices in between.
    Jarvik GP; Amendola LM; Berg JS; Brothers K; Clayton EW; Chung W; Evans BJ; Evans JP; Fullerton SM; Gallego CJ; Garrison NA; Gray SW; Holm IA; Kullo IJ; Lehmann LS; McCarty C; Prows CA; Rehm HL; Sharp RR; Salama J; Sanderson S; Van Driest SL; Williams MS; Wolf SM; Wolf WA; ; ; Burke W
    Am J Hum Genet; 2014 Jun; 94(6):818-26. PubMed ID: 24814192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The legal risks of returning results of genomics research.
    Clayton EW; McGuire AL
    Genet Med; 2012 Apr; 14(4):473-7. PubMed ID: 22323070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project.
    Biesecker LG
    Genet Med; 2012 Apr; 14(4):393-8. PubMed ID: 22344227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit Sharing for Human Genomics Research: Awareness and Expectations of Genomics Researchers in Sub-Saharan Africa.
    Munung NS; de Vries J
    Ethics Hum Res; 2020 Nov; 42(6):14-20. PubMed ID: 33136331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical implications of the use of whole genome methods in medical research.
    Kaye J; Boddington P; de Vries J; Hawkins N; Melham K
    Eur J Hum Genet; 2010 Apr; 18(4):398-403. PubMed ID: 19888293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics and High-Consequence Infectious Diseases: A Scoping Review of Emerging Science and Potential Ethical Issues.
    Boyce AM; Garibaldi BT
    Health Secur; 2019; 17(1):62-68. PubMed ID: 30724614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research.
    Tabor HK; Berkman BE; Hull SC; Bamshad MJ
    Am J Med Genet A; 2011 Dec; 155A(12):2916-24. PubMed ID: 22038764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent in the context of pharmacogenomic research: ethical considerations.
    Howard HC; Joly Y; Avard D; Laplante N; Phillips M; Tardif JC
    Pharmacogenomics J; 2011 Jun; 11(3):155-61. PubMed ID: 21445091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increasing role of genetics and genomics in women's health.
    Klein EL
    Nurs Womens Health; 2014; 18(2):149-53. PubMed ID: 24750654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disclosure of research results from cancer genomic studies: state of the science.
    Dressler LG
    Clin Cancer Res; 2009 Jul; 15(13):4270-6. PubMed ID: 19549775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethical implications of stratifying by race in pharmacogenomics.
    Lee SS
    Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing in psychiatric research: what study participants need to know about research findings.
    Mathieu G; Groisman IJ; Godard B
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2119-27. PubMed ID: 23725748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skepticism in the Genomic Era.
    Zacharias RL
    Hastings Cent Rep; 2016 Nov; 46(6):inside front cover. PubMed ID: 27875644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and children: meeting the ethical challenges.
    Freund CL; Clayton EW
    Am J Pharmacogenomics; 2003; 3(6):399-404. PubMed ID: 14672521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return of research results from genomic biobanks: cost matters.
    Bledsoe MJ; Clayton EW; McGuire AL; Grizzle WE; O'Rourke PP; Zeps N
    Genet Med; 2013 Feb; 15(2):103-5. PubMed ID: 22935716
    [No Abstract]   [Full Text] [Related]  

  • 18. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric ethics in the age of molecular medicine.
    Barfield RC; Kodish E
    Pediatr Clin North Am; 2006 Aug; 53(4):639-48. PubMed ID: 16872997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do patients and research subjects have a right to receive their genomic raw data? An ethical and legal analysis.
    Schickhardt C; Fleischer H; Winkler EC
    BMC Med Ethics; 2020 Jan; 21(1):7. PubMed ID: 31948449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.